CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
Abstract The pharmacological activation of the cannabinoid receptor type 2, CB2, has been shown to elicit anti-tumoral mechanisms in different…
Abstract The pharmacological activation of the cannabinoid receptor type 2, CB2, has been shown to elicit anti-tumoral mechanisms in different…